Uniform solid-phase extraction procedure for toxicological drug screening in serum and urine by HPLC with photodiode-array detection

Clinical Chemistry

Volumn 43, Issue 2, 1997, Pages 312-325

  Lai, Chi Kong ^a   Lee, Ting ^a   Au, Kam Ming ^a   Chan, Albert Yan Wo ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

abused drugs; chromatography; drug metabolism and disposition; reversed phase; toxicology

Indexed keywords

ALPRAZOLAM; AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANNABINOID DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; COCAINE; CODEINE; DEXTROPROPOXYPHENE; DRUG METABOLITE; EPHEDRINE; FLUOXETINE; FUROSEMIDE; GLUCURONIDE; IMIPRAMINE; METHADONE; METHAQUALONE; METOPROLOL; MIDAZOLAM; MORPHINE; NAPROXEN; NORTRIPTYLINE; OPIATE DERIVATIVE; PHENCYCLIDINE; RANITIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VERAPAMIL;

ARTICLE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG CONJUGATION; DRUG INTOXICATION; DRUG ISOLATION; DRUG OVERDOSE; DRUG RETENTION; DRUG SCREENING; DRUG TRANSFORMATION; DRUG URINE LEVEL; HUMAN; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY; URINALYSIS;

EID: 0031025440     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.2.312     Document Type: Article

References (37)

1. Litovitz TL, Felberg L, Soloway RA, Ford M, Gellar R. 1994 annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med 1995:13;551-97.
2. Lo DST, Chao TC, Tay MK. Toxicology services in Singapore. Ann Acad Med 1993;22:37-42.
3. Henderson A, Wright M, Pond SM. Experience with 732 acute overdose patients admitted to an intensive care unit over six years. Med J Aust 1993;158:28-30.
4. Chan TYK, Critchley JAJH, Chan MTV, Yu CM. Drug overdose and other poisoning in Hong Kong - The Prince of Wales Hospital (Shatin) experience. Hum Exp Toxicol 1994;13:512-5.
5. Widdop B. Hospital toxicology & drug abuse screening. In: Moffat AC, ed. Clarke's isolation and identification of drugs, 2nd ed. London, UK: Pharmaceutical Press, 1986:3-34.
6. Osterloh JD. Utility and reliability of emergency toxicologic testing. Emerg Med Clin North Am 1990;8:693-723.
7. Maurer HH. Methods. In: Pfleger K, Maurer HH, Weber A, eds. Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites, 2nd ed. Weinheim, Germany: VCH, 1992:3-32.
8. Binder SR, Regalia M, Biaggi-McEachern M, Mazhar M. Automated liquid Chromatographic analysis of drugs in urine by on-line sample clean-up and isocratic multi-column separation. J Chromatogr 1989;473:325-41.
9. Logan BK, Stafford DT, Tebbett IR, Moore CM. Rapid screening for 100 basic drugs and metabolites in urine using cation exchange solid-phase extraction and high-performance liquid chromatography with diode array detection. J Anal Toxicol 1990;14:154-9.
10. Turcant A, Premel-Cabic A, Cailleux A, Allain P. Toxicological screening of drugs by microbore high-performance liquid chromatography with photodiode-array detection and ultraviolet spectral library searches. Clin Chem 1991;37:1210-5.
11. Puopolo PR, Volpicelli SA, Johnson DK, Flood JG. Emergency toxicology testing (detection, confirmation, and quantification) of basic drugs in serum by liquid chromatography with photodiode array detection. Clin Chem 1991;37:2124-30.
12. Puopolo PR, Pothier ME, Volpicelli SA, Flood JG. Single procedure for detection, confirmation, and quantification of benzodiazepines in serum by liquid chromatography with photodiode array detection. Clin Chem 1991;37:701-6.
13. Bogusz M, Wu M. Standardized HPLC/DAD system, based on retention indices and spectral library, applicable for systematic toxicological screening. J Anal Toxicol 1991;15:188-97.
14. Drummer OH, Kotsos A, McIntyre IM. A class-independent drug screen in forensic toxicology using a photodiode array detector. J Anal Toxicol 1993;17:225-9.
15. Demedts P, Wauters A, Franck F, Neels H. Evaluation of the REMEDi® drug profiling system. Eur J Clin Chem Clin Biochem 1994;32:409-17.
16. Koves EM. Use of high-performance liquid chromatography-diode array detection in forensic toxicology. J Chromatogr A 1995;692: 103-19.
17. de Zeeuw RA, Hartstra J, Franke JP. Potential and pitfalls of Chromatographic techniques and detection modes in substance identification for systematic toxicological analysis. J Chromatogr A 1994;674:3-13.
18. Wolff K, Sanderson MJ, Hay AWM. A rapid horizontal TLC method for detecting drugs of abuse. Ann Clin Biochem 1990;27:482-8.
19. Lillsunde P, Korte T. Comprehensive drug screening in urine using SPE and combined TLC and GC-MS identification. J Anal Toxicol 1991;15:71-81.
20. Ferrara SD, Tedeschi L, Frison G, Castagna F. Solid-phase extraction and HPLC-UV confirmation of drugs of abuse in urine. J Anal Toxicol 1992;16:217-22.
21. Sollans A, Carnicero M, Torre R, Segura J. Comprehensive screening procedure for detection of stimulants, narcotics, adrenergic drugs, and their metabolites in human urine. J Chromatogr 1995;19:104-14.
22. Chen XH, Wijsbeek J, Franke JP, de Zeeuw RA. A single column procedure on Bond Elut Certify for systematic toxicological analysis of drugs in plasma and urine. J Forensic Sci 1992;37:61-71.
23. Chen XH, Franke JP, Wijsbeek J, de Zeeuw RA. Isolation of acidic, neutral and basic drugs from whole blood using a single mixed-mode solid-phase extraction column. J Anal Toxicol 1992;16: 351-5.
24. Chen XH, Franke JP, de Zeeuw RA. Principles of solid-phase extraction. In: Liu RH, Goldberger BA, eds. Handbook of workplace drug testing. Washington, DC: AACC Press, 1995:1-22.
25. Stockley IH, ed. Drug interactions, 3rd ed. Oxford, UK: Blackwell Scientific Publishers, 1995:932pp.
26. Baselt RC, Crabey RH. Disposition of toxic drugs and chemicals in man, 4th ed. Foster City, CA: Chemical Toxicology Institute, 1995:802pp.
27. Luo H, Hawes EM, Mckay G, Korchinski ED, Midha KK. The quaternary ammonium-linked glucuronide of doxepin: a major metabolite in depressed patients treated with doxepin. Drug Metab Dispos 1991;19:722-4.
28. Simonsson P, Lidén A, Lindberg S. Effect of β-glucuronidase on urinary benzodiazepine concentrations determined by fluorescence polarization immunoassay. Clin Chem 1995;41:920-3.
29. Meatherall R. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required. J Anal Toxicol 1994;18: 385-90.
30. Law B, Stafford LE. The use of ultraviolet spectra and Chromatographic retention data as an aid to metabolite identification. J Pharm Biochem Anal 1993;11:729-36.
31. Kalow W, Grant DM. Pharmacogenetics. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease, 7th ed. New York: McGraw Hill, 1995:293-326.
32. Tilstone WJ, Stead AH. Pharmacokinetics, metabolism, and the interpretation of results. In: Moffat AC, ed. Clarke's isolation and identification of drugs, 2nd ed. London, UK: Pharmaceutical Press, 1986:276-305.
33. Hill DW, Kind AJ. Reversed-phase solvent-gradient HPLC retention indexes of drugs. J Anal Toxicol 1994;18:233-42.
34. Bogusz M, Erkens M. Influence of biological matrix on Chromatographic behavior and detection of selected acidic, neutral, and basic drugs examined by means of a standardized HPLC-DAD system. J Anal Toxicol 1995;19:49-55.
35. Maier RD, Bogusz M. Identification power of a standardized HPLC-DAD system for systematic toxicological analysis. J Anal Toxicol 1995;19:79-83.
36. Bogusz M, Hill DW, Rehorek A. Comparability of RP-HPLC detection indices of drugs in three databases. J Liq Chromatogr Rel Technol 1996;19:1291-316.
37. Strasters JK. Chemometrics and photodiode array detection. In: Huber L, George SA, eds. Diode array detection in HPLC (Chromatographic Science series, Vol. 62). New York: Marcel Dekker, 1993:127-62.